Currently Viewing:
ACO & Emerging Healthcare Delivery Coalition® Spring 2017
Dr Mark Friedberg: How Practices Shifting to Value-Based Care Models Can Alleviate Burnout
November 16, 2017
Dr Frank James on the Role of Stigma in Addiction Treatment
November 15, 2017
Dr Darius Lakdawalla Discusses the Meaning and Measure of "Value" in Healthcare
September 13, 2017
Dr Darius Lakdawalla on the Willingness to Pay for a Cure
August 02, 2017
Currently Reading
Dr Clifford Goodman: A Look at the Present and Future of Value Frameworks
July 22, 2017
Dr Sachin Jain Discusses CareMore's Community Partnerships, Internal Programs
July 18, 2017
Lee Barrett Outlines Best Practices for Healthcare Cybersecurity
July 15, 2017
Michael Griffin on Aligning Payers With Population Health and Social Determinants
July 12, 2017
Dr Clifford Goodman on Possible Drug Pricing Solutions Adapted From Abroad
July 11, 2017
Dr Sachin Jain on CareMore's Mission to Manage Chronic Disease From the Dentist's Chair
July 08, 2017
Michael Griffin Discusses Daughters of Charity's Ongoing Technology Initiatives
July 03, 2017
Lee Barrett: Increased Data Exchange in Value-Based Models Poses Cybersecurity Risks
June 29, 2017
Michael Griffin: Katrina's Lasting Effects on New Orleans and Its Healthcare System
June 22, 2017
Dr Clifford Goodman Discusses Evidence-Based Drug Pricing as an Alternative to Legislative Controls
June 21, 2017
Dr Sachin Jain Focuses on Bipartisan Healthcare Efforts, Not Policy Changes
June 15, 2017
Lee Barrett on the Balance Between Strong Cybersecurity and Patient Access to Data
June 13, 2017
Dr Clifford Goodman on What to Look Forward to at the Fall 2017 ACO Coalition Meeting
June 09, 2017
Dr Sachin Jain: Discussion on Population Health Reveals Causes for Optimism
June 01, 2017
Dr Clifford Goodman: Why Focus on Value Will Persist Regardless of Changing Legislation
May 29, 2017

Dr Clifford Goodman: A Look at the Present and Future of Value Frameworks

Value frameworks are tools used to clarify cost-benefit tradeoffs in healthcare decisions, which means they can look very different depending on their intended audience, according to Clifford Goodman, PhD, moderator at the ACO Coalition spring live meeting in Scottsdale, Arizona, and senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group.


Value frameworks are tools used to clarify cost-benefit tradeoffs in healthcare decisions, which means they can look very different depending on their intended audience, according to Clifford Goodman, PhD, moderator at the ACO Coalition spring live meeting in Scottsdale, Arizona, and senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group.

Transcript (slightly modified)

There is an ever-increasing number of value frameworks: what do they get wrong and what do they get right?

The most important thing to recognize about value frameworks is that they are popping up now. Actually, since 2014, the period of 2014 to 2015, about a half a dozen what we call value frameworks emerged into great prominence here in the United States. The most important thing is that people wanted to make more explicit the tradeoffs of benefits and costs in healthcare.

Value frameworks also recognize that value is in the eye of the beholder. Different stakeholders in the healthcare system obviously have different perspectives on what comprises value. Is it effectiveness and efficacy? Is it toxicity and adverse events? To what extent is it cost, and is it cost just of the therapy and the diagnostic itself, or is it cost savings? Is it offsets in other areas? To what extent are they long-term costs versus short-term costs?

Then there are other sorts of aspects that have come into understanding value, such as things like innovation, or are you the first therapy for an otherwise failed disease, or is this a rare condition for which this is a new therapy? Those different factors matter differently to different stakeholders, so again, the most important thing about the value frameworks is that we’re actually trying to define and assess value.

Now, as of now, they all have strengths and weaknesses, and frankly the main strengths and weaknesses are that they look different from each other. That’s actually a criticism that is not really appropriate, because these value frameworks are designed by different stakeholders with different target audiences in mind, all of which have different criteria or factors that matter differently to them.

So, I’m not so much looking or caring about the weaknesses of value frameworks right now. I’m more optimistic that we will be spending some time to see how they evolve and respond to stakeholder interest. Do the target audiences find them of use or don’t they? The best thing to realize about them now is that they are continuing to evolve. Those that develop the value frameworks are, for the most part, listening and gaining feedback and tweaking along the way. That’s my look at the current and future status of value frameworks.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!